Customer Publication

Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation

Authors: H. Zeng et al.

Journal: Cancer Cell (2018)

Institution: Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA

Research Areas: Melanoma

Cell Lines: Melanocytes (Engineered primary human melanocytes)

Summary: Utilizing precision genetic engineering and PHI’s HoloMonitor technology, scientists at University of California, San Francisco, have for the first time been able to monitor and map how mutations break down the genetic protection against skin cancer, allowing harmless moles to transform into invasive skin cancer.

Keywords: HoloMonitor M4, Cell division, Cell death, Senescence, Cell motility , CDKN2A, Melanoma, Invasion, Melanocytes, CRISPR engineering, E2F1 BRN2

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
+46 46 38 60 80

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
+1 617-963-5150


VAT: SE556542781101

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2